Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation



Status:Completed
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:21 - 65
Updated:12/5/2018
Start Date:March 2009
End Date:March 2015

Use our guide to learn which trials are right for you!

The purpose of this research is to study the effects of Vitamin D supplementation on the
body's response to insulin (a hormone that controls blood sugar), on inflammation and/or on
specific cells and processes in fat tissue, and on function of skeletal muscle and joints.

Over the last several years, studies have shown that low vitamin D levels may increase risk
of development of Type 2 Diabetes. The investigators will administer vitamin D3
(Cholecalciferol) to nondiabetic, insulin resistant subjects with vitamin D deficiency (total
vitamin D levels < 20 ng/ml) to increase the level of vitamin D initially to 30-50ng/ml and
then to higher normal range of 51-75 ng/ml. The investigators will study its effects on
insulin action, adipose tissue inflammation, and musculoskeletal function.

Inclusion Criteria:

- Age 21-65 years old

- Serum 25(OH)D<20ng/ml

- Insulin Resistant based on HOMA-IR score of >3

- Able and willing to provide informed consent

- BMI 25-39

- For T2DM: A1c between 7.5 and 9.5

Exclusion Criteria:

- FPG greater than or equal to 126 mg/dl or 2-hour-OGTT plasma glucose greater than or
equal to 200 mg/dl

- HIV/AIDS

- History of any cancer

- Sarcoidosis

- Alcohol or substance abuse

- Cushing's syndrome

- Primary hyperparathyroidism

- Nephrolithiasis

- Pregnancy or breastfeeding

- Regular visits to a tanning salon

- Hypercalcemia or hypocalcemia

- Untreated or uncontrolled hypertension

- Any chronic illness requiring medication, other than arthritis, hypertension and
hyperlipidemia
We found this trial at
1
site
?
mi
from
Bronx, NY
Click here to add this to my saved trials